FINASTERIDE MICRONIZED

Micronized finasteride inhibits 5‑α‑reductase, reducing DHT levels to treat hair loss and prostate enlargement. Side effects include decreased libido, erectile dysfunction, and breast tenderness.

SKU: cffefd5744f9 Category: Tag:

Product Description


Mechanism of Action

Micronized finasteride enhances dissolution and absorption. Finasteride inhibits 5‑alpha reductase type II, reducing dihydrotestosterone (DHT) formation and modulating androgen‑responsive tissues.

Benefits and Advantages

Used in androgen‑pathway research, prostate‑biology studies and hair‑follicle DHT suppression modelling.

Side Effects and Risks

Risks include sexual dysfunction, mood changes and hormonal disturbances.

Datasheet


Molecular Formula

C23H36N2O2

Molecular Weight

372.55 g/mol

CAS Number

98319-26-7

Storage Condition

Store in a cool, dry place; protect from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno(5,4-f)quinoline-7-carboxylic acid tert-butylamide; 4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide; RefChem:1071733; 1212235-84-1; N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide

IUPAC/Chemical Name

(17β)-N-tert-butyl-carbamoyl-4-aza-5α-androst-1-en-3-one

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download